Diagnostics, Inc. Reports Second Quarter 2022 Financial Results
Aug 11 (Reuters) - Co-Diagnostics Inc CODX.O :
* CO-DIAGNOSTICS, INC. REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS
* Q2 LOSS PER SHARE $0.08
* Q2 REVENUE $5.0 MILLION VERSUS $27.4 MILLION
Source text for Eikon: ID:nPn6Jqnl8a
Further company coverage: CODX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Co-Diagnostics
See all newsDiagnostics' Joint Venture Cosara Diagnostics Announces Publication Of Peer-Reviewed Hpv Screening Study Using Cosara's Saragene® Test
Diagnostics - Cosara To Initiate Sales Activities Across India And South Asia
Diagnostics’ Brian Brown Stepped Down As CFO Effective September 2
Diagnostics Q2 revenue rises slightly amid international expansion
Diagnostics - Amends Equity Distribution Agreement With Maxim Group For Common Stock Sale - SEC Filing